Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rina Plattner

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer Research|June 3, 2006
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cellsDivyamani Srinivasan, Rina Plattner
Molecular & Cellular Oncology|September 26, 2018
EnABLing Cathepsin-Driven Melanoma MetastasisRakshamani Tripathi, Rina Plattner
Genes & Cancer|December 11, 2012
Activation of abl family kinases in solid tumorsSourik S Ganguly, Rina Plattner
Cancer Chemotherapy and Pharmacology|April 28, 2009
MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell linesJonathan T Sims, Rina Plattner
Current Pharmacology Reports|February 13, 2019
EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cellsRakshamani Tripathi, Zulong Liu, Rina Plattner
Cellular Signalling|March 12, 2009
Reciprocal regulation of Abl and receptor tyrosine kinasesDivyamani Srinivasan, David M Kaetzel, Rina Plattner
The EMBO Journal|October 9, 2003
Abl tyrosine kinases are required for infection by Shigella flexneriElizabeth A Burton, Rina Plattner, Ann Marie Pendergast
Journal of Cell Science|October 2, 2008
SHP-2 is a novel target of Abl kinases during cell proliferationSayan Mitra, Carol Beach, Gen-Sheng Feng, et al.
Molecular and Cellular Biology|March 3, 2004
Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptorRina Plattner, Anthony J Koleske, Andrius Kazlauskas, et al.
Plos One|February 6, 2013
Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1Jonathan T Sims, Sourik S Ganguly, Holly Bennett, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|June 3, 2006
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cellsDivyamani Srinivasan, Rina Plattner
Molecular & Cellular Oncology|September 26, 2018
EnABLing Cathepsin-Driven Melanoma MetastasisRakshamani Tripathi, Rina Plattner
Genes & Cancer|December 11, 2012
Activation of abl family kinases in solid tumorsSourik S Ganguly, Rina Plattner
Cancer Chemotherapy and Pharmacology|April 28, 2009
MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell linesJonathan T Sims, Rina Plattner
Current Pharmacology Reports|February 13, 2019
EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cellsRakshamani Tripathi, Zulong Liu, Rina Plattner
Cellular Signalling|March 12, 2009
Reciprocal regulation of Abl and receptor tyrosine kinasesDivyamani Srinivasan, David M Kaetzel, Rina Plattner
The EMBO Journal|October 9, 2003
Abl tyrosine kinases are required for infection by Shigella flexneriElizabeth A Burton, Rina Plattner, Ann Marie Pendergast
Journal of Cell Science|October 2, 2008
SHP-2 is a novel target of Abl kinases during cell proliferationSayan Mitra, Carol Beach, Gen-Sheng Feng, et al.
Molecular and Cellular Biology|March 3, 2004
Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptorRina Plattner, Anthony J Koleske, Andrius Kazlauskas, et al.
Plos One|February 6, 2013
Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1Jonathan T Sims, Sourik S Ganguly, Holly Bennett, et al.
Pageof 3